Evaluation of Diagnostic Accuracy of MCG(Magnetocardiography) Scan in Suspected Coronary Artery Disease

Study acronym: EDAM-CAD
StatusCompleted
PhaseNot specified
SponsorAMCG
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial status changed: Unknown → Completed Show 6 more changesShow less
    • Final enrollment: 600 participants (planned 908)
    • Primary completion date changed from estimate of Dec 2025 to Dec 30, 2025
    • Study completion date changed from estimate of Jan 2026 to Dec 30, 2025
    • Interventions: Rest MCG scan (Diagnostic Test), Rest/Stress MCG scan (Diagnostic Test) to Rest MCG scan (Diagnostic Test), Rest/Stress MCG scan (Diagnostic Test)
    • Eligibility criteria expanded, about 8 words
    • Site details revised at 2 of 2 sites
  2. Minor Changed Registry marked status Unknown; last known: Recruiting
  3. Notable Enrollment target: 554 to 908v3 Show 5 more changesShow less
    • Primary completion date: Feb 2025 to Dec 2025
    • Start date changed from estimate of Jun 2023 to Jun 24, 2024
    • Trial status: Not Yet Recruiting to Unknown
    • Study completion date: May 2025 to Jan 2026
    • Site details revised at 2 of 2 sites
  4. Minor Eligibility criteria revised
    • Secondary endpoint revised
    • Study description revised
    v2
  5. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This multicenter clinical trial is designed to evaluate the diagnostic accuracy of MCG scan in detecting significant CAD compared to the reference standard CAG.
Trial Details
NCT Number NCT05825911
Lead Sponsor AMCG
Conditions
(from sponsor)
Coronary Artery Disease
Related terms Coronary Artery Disease
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov